Retraction to: Acta Pharmacologica Sinica
The Editor has retracted this article [1] because some of the figures have errors which were introduced during the process of integrating and editing the original images (Figs. 1 and 3). Due to the fact that the research was conducted over ten years ago, the original data can no longer be found, and the article cannot be corrected. All authors agree to this retraction.
REFERENCE
1. Dai LC, Wang X, Yao X, Min LS, Ping JL, He JF. Antisense oligonucleotides targeting midkine inhibit tumor growth in an in situ human hepatocellular carcinoma model. Acta Pharmacologica Sinica. 2007 Mar;28(3):453–8.
Author information
Authors and Affiliations
Corresponding author
Additional information
1Project supported by a grant from the Zhejiang Province Medicine and Sanitation Research Foundation (No 2003A077) and Huzhou Natural Science Foundation(No 2004SZX07-11).
About this article
Cite this article
Dai, Lc., Wang, X., Yao, X. et al. Retraction Note: Antisense oligonucleotides targeting midkine inhibit tumor growth in an in situ human hepatocellular carcinoma model. Acta Pharmacol Sin 40, 1502 (2019). https://doi.org/10.1038/s41401-019-0236-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41401-019-0236-6
